A Study of Eltrekibart (LY3041658) in Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Lilly Centre for Clinical Pharmacology, Singapore, Singapore
Study coordinator · +65 6413 9838
Contact: Principal Investigator (Greg Li)

Study leads

Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Glendale, United States · Baltimore, United States

A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2072 Tablets

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Beijing, China

Impact of Exogenous Ketones on Breathing in Healthy Volunteers

Healthy Volunteer

Abroad (travel likely)RecruitingEARLY_PHASE1

Baltimore, United States

Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs

Healthy

Abroad (travel likely)RecruitingPHASE1

London, United Kingdom